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ABSTRACT 
Two different methods have been used to fatigue test four bone cements. Each method has been used 
previously, but the results have not been compared. One method tests at least 10 samples over a single 
stress range in tension only and uses Weibull analysis to calculate the median number of cycles to failure 
and the Weibull modulus. The second test regime uses fewer specimens at various stress levels tested in 
fully reversed tension-compression, and generates a stress versus number of cycles to failure (S-N) or 
Wöhler curve. Data from specimens where the fracture surface contains pores greater than 1mm across is 
rejected. The single stress level test is quicker to perform however, provides only tensile fatigue data, but 
the material tested includes pores, thus more physiological cement is tested. The multiple stress level 
testing regime uses combined tension and compression loading and multiple stress levels, thus more 
physiological loading, but excludes specimens where the defects are greater than 1mm across, so is less 
representative of cement in vivo. The fatigue lives between the cements were up to a factor 15 different for 
the single stress level tension only tests, while they were only a factor of 2 different in the fully reversed 
tension-compression testing. 
The single stress level results are more effected by surface flaws, thus the differences found using the 
multiple stress levels are more indicative of differences in the fatigue lives of the cements. However, the 
single stress level tests are quicker, so are useful for initial screening. 
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INTRODUCTION 
Fatigue failure of bone cement is considered to 
be a precipitating factor in the aseptic 
loosening of cemented joint replacements. 
Failure of cement has three effects, firstly, it 
reduces the ability of the cement mantle to 
provide uniform load transfer from the implant 
to the supporting bone [1], thus altering the 
biomechanics of the implant - supporting bone 
system. Secondly, fracture of the cement leads 
to the production of wear particles of cement 
and opacifier which both directly increase 
bone resorption [2,3] and increase the 
production of polyethylene wear particles 
which have also been shown to increase bone 
resorption [4]. Thirdly, the failure of the 
cement allows wear particles to track from the 
implant-cement interface to the cement-bone 
interface. All these mechanisms combine to 
accelerate implant loosening and thus 
eventually to implant revision. Approximately 
75% of hip revision surgery is due to aseptic 
loosening [5], costing in the 1990s an average 
of US$ 21,224 per revision [6]. Thus 
investigation of the fatigue behaviour must be 
an essential component of pre-clinical 
assessment of new bone cements.  
However, various methods have been 
described to perform fatigue testing of bone 
cement and to compare the fatigue lives of 
different cements. Two of the more common 
methods are fatigue testing over a single stress 
range of at least 10 samples, using minimal 
exclusion criteria, followed by Weibull 
statistical analysis to compare the mean fatigue 
lives. The second method is to develop a 
complete S-N or Wöhler curve by testing a 
smaller number of specimens at each of a 
series of stress levels [7]. From this data, both 
the mean number of cycles to failure at each 
stress level and the regression line for the each 
cement, calculated using the logarithm to base 
10 of the number of cycles to failure, can be 
compared.  
The first of these methods, single stress level 
tension only fatigue testing was used by 
Harper and Bonfield [8]. They used half size 
ISO 527 specimens, that is specimens 75 mm 
long and nominally 3.5mm thick with a gauge 
section 25mm long and 5mm wide. Their 
testing was performed between 0.3 and 22MPa 
tension only in air at room temperature. They 
compared the fatigue lives of 10 different 
cements mixed at atmospheric pressure but 
polymerised under pressure and used Weibull 
statistics for comparison. They found a huge 
range in the median fatigue lives ranging from 
164 cycles to failure for Boneloc®, through to 
27,892 for Palacos R and 26,667 for Simplex 
P, and for these last two cements the long 
fatigue lives matched the reported good 
clinical outcome with a low risk for revision 
[5]. Johnson et al. [9] used cylindrical cross-
section specimens and a slightly lower stress 
range of 0.3 to 20MPa to show that the fatigue 
life increased when the test frequency was 
increased or when tested in water at 24˚C, 
while increasing the temperature to 37˚C 
decreased the fatigue life. Dunne et al. [10] 
investigated the relationship between porosity 
and fatigue properties and found that reducing 
the mixing pressure greatly improved the mean 
fatigue strength. Both Harper and Bonfield [8] 
and Dunne et al. [10] tested and analysed the 
data from every specimen.Jeffers et al. [12] 
similarly used tension-tension fatigue with flat 
test specimen, but using four stress levels, at 
20, 15, 11, and 7 MPa with a constant R ratio 
of 0.1, that is the minimum stress was 10% of 
the maximum stress and produced an S-N 
curve.  
In comparison to these flat dumbbell 
specimens Lewis [15] and Lewis et al. [16] 
used cylindrical dumbbells to ASTM 2118 [7]. 
Their specimens were aged and tested in air at 
22˚C, only data from specimens with surface 
flaws or internal pores less 0.25mm in 
diameter was included. Lewis [15] applied 
fully reversed tension-compression at ±15MPa 
and found that both vacuum mixing and 
increasing the test frequency increased the 
fatigue life. Lewis & Janna [18] investigated 
the impact of the cross-sectional shape on the 
fatigue life outcome. Two specimen types were 
used, flat dumbbell specimens to ASTM D-
638-01 Type IV which were compared to 
circular specimens to F2118-01a. These gave 
specimens with the same nominal cross-
sectional area, but different surface areas. 
Three cements were tested at ±15 MPa and at a 
frequency of 5 Hz, the circular cross-section 
specimens had longer fatigue lives than the 
rectangular cross-section specimens.  
Thus two major types of tests and specimens 
have been used, rectangular cross-section and a 
single load regime and circular cross-section at 
multiple stress levels. The first of these test 
regimes requires fewer specimens and thus less 
time to complete the tests, but the question 
remains whether information is lost by not 
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going through the full ASTM F2118 test 
regime at multiple stress levels.  
Recently Refobacin® Bone Cement R and 
Refobacin® Plus Bone Cement have been  
developed as to be equivalent to Refobacin 
Palacos® R and Palamed® G respectively. 
These new cements are generally equivalent to 
the previous formulations, although with minor 
changes in the colourant used to differentiate 
the cement from the surrounding bone. Dall et 
al. [19] using static strength tests, such as 
impact, compression, bending and tension tests 
have found no significant mechanical 
differences between these cements, although 
they did see differences in the handling 
behaviour [20]. However, it is not clear 
whether any influence will be seen on the 
fatigue life. 
In this study these four cements have been 
tested using both fully reversed tension 
compression on cylindrical specimens and in 
tension only on rectangular cross-section 
specimens in saline at 37˚C and the results 
have been compared. To clarify the differences 
found, density measurements, fractography 
and radiography have been performed. 
 
MATERIALS AND METHODS 
Four bone cements (Table 1) were tested, 
namely Refobacin® Bone Cement R 
andRefobacin® Plus Bone Cement (Biomet 
Cementing Technologies, Sjöbo, Sweden), and 
Refobacin Palacos® R and Palamed® G 
(manufactured by Kulzer). All these cements 
are based on poly(methylmethacrylate with 
methylacrylate co-polymer). These cements 
contain zirconium dioxide as an opacifier and 
gentamicin antibiotic in the powder phase. 
(Table 1)  
 
Table 1.  Composition of the four bone cements tested (Manufacturer’s data). 
  Refobacin® 
Bone 
Cement R  
Refobacin® 
Palacos R  
Refobacin® 
Plus Bone 
Cement  
Palamed® G 
Powder 
(40.8/44.9 g) 
Poly(methyl acrylate, 
methyl methacrylate) 
33.6 g 33.6 g 38.3 g 38.3 g 
 Gentamicin sulphate  0.8 g  0.8 g  0.9 g  0.9 g  
 Zirconium dioxide 6.1 g 6.1 g 5.3 g 5.3 g 
 Benzoyl peroxide 0.3 g 0.3 g 0.4 g 0.4 g 
 Chlorophyll - + - + 
Monomer (20 
ml) 
Methyl methacrylate 18.4 g 18.4 g 18.4 g 18.4 g 
 N,N-dimethyl-p-
toluidine 
0.4 g 0.4 g 0.4 g 0.4 g 
 Chlorophyll + + + + 
Total mass  59.6g 59.6g 63.7g 63.7g 
Powder to 
Liquid ratio 
/g ml-1 
 2.04 2.04 2.245 2.245 
Wt% 
Gentamicin 
sulphate 
 1.3% 1.3% 1.4% 1.4% 
Wt% zirconium 
dioxide 
 10.2% 10.2% 8.3% 8.3% 
It should be noted that 18.8g of liquid monomer is 20ml of liquid. 
 
The studies were performed in two laboratories 
and the results were blind between the 
laboratories until the combined analysis was 
performed for this study. In all cases the 
cements were prepared in the manufacturer’s 
recommended manner. The cements were 
stored and mixed at room temperature. All the 
bone cements were vacuum-mixed in 
Optivac® mixing systems (Biomet Cementing 
Technologies AB, Sjöbo, Sweden) and two 
minutes after the start of mixing were injected 
into the moulds. Two types of fatigue testing 
were performed. 
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Single Stress Level Tension-Tension Fatigue 
Tests 
For the single stress level tension only tests 
half-size ISO 527 flat dumbbell specimens, 
nominally 4mm thick with a gauge section 
25mm long and 5mm wide were directly 
moulded in polytetrafluoroethylene (PTFE) 
moulds, giving single stress level rectangular 
(SSR) specimens Table 2). After 20 to 30 
minutes under a pressure of 820MPa the 
specimens were removed from the mould and 
were examined for pores against a strong light 
and specimens containing visible pores 
(>1.0mm diameter) were excluded from the 
study. The SSR specimens were loaded under 
force control between 0.3 and 22 MPa at 2 Hz 
using sinusoidal loading in tension-tension as 
described by Harper and Bonfield [8] and 
others. Testing was performed using an Instron 
8511.20 Load frame with an MTS controller 
running MTS Teststar II® software. The 
number of cycles to failure was recorded and 
the data from all tested specimens was 
included. A minimum of 11 and up to 31 
specimens of each cement were tested. The 
Weibull number was calculated using eqn 1: 
! 
Weibull number =  ln(ln(1- ln(1- probability of failure)))
  (1)  
where the probability of failure was calculated 
using Bernard’s correction. A Weibull model 
of the natural logarithm of number of cycles to 
failure versus the Weibull number was used to 
calculate the mean number of cycles to failure 
and to display the data.  
 
TABLE 2 Comparison of test specimens 
 Single Stress Level rectangular 
SSR specimens  
Multiple stress level cylindrical 
MSC specimens 
Standard Used ASTM ISO 
Cross section Rectangular – 4mm × 5mm 
Circumference = 18mm 
Cross-sectional area = 20mm2 
Circular – diameter 5mm 
Circumference = 15.7mm  
Cross-sectional area = 19.6mm2 
Gauge section Length 25mm  
Surface area 450mm2 
Length 10mm  
surface area 157mm2 
Manufacturing pressure 820MPa Yes but not quantified 
Machined before testing No Yes from rods of cement 
 
 
Multiple Stress Range Fully Reversed 
Tension-Compression Fatigue Tests 
To generate the stress-number of cycles or 
Wöhler curve, the cement, mixed as before, 
was injected into 10mm diameter cylindrical 
stainless steel moulds which were pressurized 
for a few minutes. The mould was then placed 
in an incubator at 37˚C for at least one hour to 
allow setting and polymerization of the 
cement, prior to specimen removal from the 
moulds. After a minimum of 24 hours at 37˚C 
in air the specimens were machined into 
cylindrical dumbbells according to ATSM 
F2118-03 [7], giving specimens with a 
nominal 5mm diameter by 10mm long gauge 
length with 8mm diameter gripping shoulders, 
giving multiple stress level cylindrical (MSC) 
specimens (Table 2). Specimens were 
radiographed to exclude those with pores 
greater than 1mm in diameter, compared to the 
pore size of 1.7mm determined by Cristofolini 
et al. [22] to give a 50% chance of initiating 
specimen fracture. Testing was performed at 5 
Hz in fully reversed tension-compression at 
±10.0, ±12.5, ±15.0, ±20.0 or ±30.0 MPa 
maximum stress and were tested to failure or 5 
million load cycles, the run-out value given by 
ASTM F2118 [7]. Eight specimens were tested 
per stress level. If a pore greater than 1mm 
across was visible on the fracture surface, the 
data was rejected and the specimen replaced. 
The S-N or Wöhler curve was generated by 
plotting the logarithm to base 10 of the number 
of cycles to failure against the maximum 
applied stress.  
For both fatigue test regimes all testing was 
performed at 37˚C in phosphate buffered saline 
(PBS) on specimens that had been aged for 
between 1 and 6 weeks in PBS at 37˚C, the 
aging time range suggested by Lewis and 
Austin [21]. Both types of specimens were 
held in MTS immersible axial-torsion 
manually tightened stainless steel grips 
irrigated with a continuous flow of PBS at 
37˚C throughout the testing (Figure 1).  
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Figure 1 Close up of a test specimen showing the flowing PBS fully covering the specimen 
 
Physical Characterisation 
After the fatigue testing and data analysis 
specimens were selected for physical 
characterization. In all cases specimens which 
had failed at close to the median number of 
stress cycles were chosen for analysis. From 
the SSR six were chosen. For the MSC 
specimens two subjected to each of ±10MPa, 
±15MPa and ±30MPa stress levels were 
chosen again giving a total of six specimens. 
The physical characterization consisted of 
radiographic analysis of the included pores, 
surface roughness of the surfaces of the gauge 
lengths, density measurements of the gauge 
region and Scanning Electron Micrography 
(SEM) of the fracture surfaces. 
 
Radiographic Analysis 
Six specimens per group, that is cement and 
test method were radiographed at 50V and 
16mAs to give an indication of the number of 
pores and their size. Radiography was 
performed using a Diacom system thus 
providing digital data In the gauge region only 
the number and size of the pores were 
estimated.  
Surface Roughness 
The surface roughness of six specimens from 
each from each set of test specimens was 
measured using a Perthometer M4P 
(Mikromess AB, Järfalla, Sweden) along the 
length of the specimen, thus perpendicular to 
the fracture surface. The SSR specimens were 
measured on one flat and one profiled side, 
over a distance of 8mm near fracture surface, 
for each specimen three measurements were 
taken per surface per specimen. For the MSC 
specimens the measurements were taken at six 
positions around the specimen, again the 
measurements taken over a distance of 8mm 
near fracture surface.  
 
Density Measurement 
To consider the effect of the different 
pressurization regimes the density of six 
specimens per cement for each test regime was 
measured using a AE 260 (Mettler Instrument 
Corporation, Greifencee, Switzerland) density 
measurement kit based on Archimedes’ 
principal. The gripping shoulders were sawn 
off the gauge section and the density of the 
gauge section alone was measured. Specimen 
density was calculated using equation 2: 
 
! 
" =
m
a
# "
water
m
a
$m
w
 (2) 
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where ma is mass of the specimen in air, mw is 
mass of the specimen when suspended in water 
and ρwater is the density of water, 0.99681 Mg 
m-3 at 26˚C.  
 
Electron Microscopy 
Scanning Electron Microscopy (SEM) was 
performed on the fracture surfaces of 
specimens which had failed close to the mean 
fatigue life for that batch of specimens, using a 
JOEL JSM700F SEM. Prior to imaging the 
specimens were coated with gold. For SSR 
specimens, one specimen of each cement was 
examined. For the MSC specimens SEM was 
performed on specimens from the highest and 
lowest applied stress levels to consider any 
effects produced by the stress levels and thus 
the number of cycles to failure.  
 
Statistical Analysis 
 The ANOVA Post Hoc Bonferroni/Dunn test 
was used to compare the number of cycles to 
failure at each individual stress level and for 
all bone cements, as well as to compare the Ra 
values and densities of the different specimens. 
 
 
 
RESULTS 
Fatigue Testing 
The results from the SSR testing are shown in 
Figure 2 plotting ln(number of cycles to 
failure) against the Weibull number. The 
median number of cycles to failure calculated 
from this graph for each cement are shown in 
Table 2. It can be seen that all four cements 
showed high correlation, with the R2 value 
being 0.95 or higher. The gradients, that is the 
Weibull moduli, and the median number of 
cycles to failure for Refobacin Palacos® R and 
Refobacin® Bone Cement R are extremely 
close. The Refobacin® Plus Bone Cement had 
the higher Weibull modulus and underwent a 
greater median number of cycles to failure than 
Palamed® G. However, using a Mann 
Whitney U test to compare these two sets of 
data showed that the differences are not 
statistically significantly. The highest Weibull 
modulus, that is the lowest range of fatigue 
lives was seen for the Refobacin® Plus Bone 
Cement. For the Refobacin Palacos® R and 
Refobacin® Bone Cement R the median 
fatigue lives are a factor of 11-12 less than that 
for Palamed® G and a factor of 13-15 less than 
that for Refobacin® Plus Bone Cement.  
 
 
Figure 2 ln(number of cycles to failure) against the Weibull number for the four different bone cements, 
Refobacin® Palacos R , Refobacin® Bone Cement R , Refobacin® Plus Bone Cement R  and 
Palamed G × 
 
The MSC data for all four cements is presented 
in an S-N (stress - number of cycles to failure) 
or Wöhler graph in Figure 3. Again the fatigue 
behaviour for Refobacin® Palacos and 
Refobacin® Bone Cement R are nearly 
identical, but in these tests Palamed® G also 
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shows similar results. The only cement to 
show an increased fatigue life is Refobacin® 
Plus Bone Cement and the difference in this 
test regime is a factor of approximately 2 over 
the entire stress range tested. When the 
individual stress levels are considered the 
differences range from, at ±30MPa, between 
Palamed® G having a factor of approximately 
1.4 greater fatigue life than Refobacin 
Palacos® R or Refobacin® Bone Cement R 
and Refobacin® Plus Bone Cement having 
approximately 2.0 greater fatigue life than 
Refobacin Palacos® R or Refobacin® Bone 
Cement R. At ±12.5MPa, Refobacin® Plus 
Bone Cement had a fatigue life over 5 times 
greater than Refobacin Palacos® R and a 
factor of 2.8 greater fatigue life than either 
Refobacin® Bone Cement R or Palmed® G. 
At ±10 MPa none of the Palamed® G 
specimens survived to 5 million cycles while 
one of the Refobacin Palacos® R, three of the 
Refobacin® Bone Cement R and five of the 
eight Refobacin® Plus Bone Cement were still 
intact after 5 million load cycles. Thus 
Refobacin® Plus Bone Cement had a fatigue 
life between 1.7 and 5 times greater than the 
other three cements depending on stress level. 
 
 
 
Figure 3 Stress vs number of cycles to failure for the four different bone cements Refobacin® Palacos R 
, Refobacin® Bone Cement R , Refobacin® Plus Bone Cement R  and Palamed G × 
 
Statistical analysis using One Way ANOVA 
Post Hoc showed no differences at ±30MPa, 
±20MPa, ±15MPa between any of the 
cements. However at ±12.5MPa and ±10MPa 
Refobacin® Plus Bone Cement had 
statistically longer fatigue lives than any of the 
other three cements. When the five stress 
levels were combined and a Two Way 
ANOVA Post Hoc test was performed again 
Refobacin® Plus Bone Cement statistically 
had a longer fatigue life than any of the other 
three cements with no differences between the 
other three cements.  
 
Physical Characterisation 
To consider the reasons for these relative 
differences in the fatigue lives in these test the 
specimens were characterized physically.  
 
Roughness 
The SSR specimens are moulded with a 
rectangular cross-section, so have sharp 
corners ,also due to the interaction with the 
mould surfaces have rougher surfaces, thus a 
greater potential for crack initiating surface 
defects, while the MSC specimens have been 
machined down from moulded specimens and 
thus would be expected to have smoother 
surfaces. The values for various sides of the 
MSC specimens were compared and found not 
to be significantly different so these data were 
combined. The Ra values for both shapes of 
specimens are shown in Table 3. No 
significant differences can be found between 
Refobacin Palacos® and Refobacin® Bone 
Cement or between Palamed G and 
Refobacin® Plus Bone Cement whether as 
SSR or MSC specimens. When comparing the 
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shape of specimens the SSR shape shows a 
trend of higher roughness compared to the 
cylindrical specimens (Table 3, p=0.06). 
Furthermore, Refobacin Palacos® and 
Refobacin® Bone Cement show higher 
roughness than Palamed G and Refobacin® 
Plus Bone Cement (p<0.05).  
 
TABLE 3 Range and median cycles to failure for the bone cements tested using ISO 527 dumbbell 
specimens loaded between 0.3 and 22MPa. 
Cement Minimum number of 
cycles to failure 
Maximum number of 
cycles to failure 
Median number of 
cycles to failure 
Refobacin® Bone 
Cement R 
711 35142 9827 
Refobacin® Palacos R  748 58527 8710 
Refobacin® Plus Bone 
Cement 
47515 211922 130010 
Palamed® G  12647 261364 107209 
 
However, due to the stylus deflection test 
method used, differences in roughness were 
measured on the submillimeter scale while 
micro and macropores, that is in the range 0.25 
to 2.0mm deep, on the surface of the 
specimens were not included in the roughness 
data. For the SSR specimens, obvious pores 
were visible on the surface of the specimens 
while minimal such pores were seen on the 
MSC specimens.  
 
 
Density measurements 
The density measurements (Table 4) show that 
there are no significant differences in density 
between the two different specimen types for 
any of the cements and therefore the density 
data of the two specimen types were 
combined. ANOVA showed that there were 
differences between the four cements with a 
higher density of 1.273±0.007Mg m-3 found 
for Refobacin® Palacos R compared with 
1.251±0.012Mg m-3 to 1.259±0.011Mg m-3 for 
the other three cements.  
 
TABLE 4 Roughness values and densities of the specimens used for the Weibull and the Wöhler analysis, 
n=6 specimens and 6 measurements per specimen for all sets of data with the rectangular cross-section 
specimens measured three times on each surface. 
Cement Ra of rectangular 
specimens 
/µm 
Ra of 
cylindrical 
specimens 
/µm 
Density of 
rectangular 
specimens 
/Mg m-3 
Density of 
cylindrical 
specimens  
/Mg m-3 
Refobacin® Bone 
Cement R  
4.61 ± 0.53 3.58 ± 2.28 1.254 ± 0.011 1.263 ± 0.009 
Refobacin® Palacos R  4.61 ± 0.91 4.05 ± 2.09 1.269 ± 0.008 1.276 ± 0.002 
Refobacin® Plus Bone 
Cement  
3.40 ± 1.06 2.51 ± 0.45 1.255 ± 0.002 1.247 ± 0.018 
Palamed® G  3.20 ± 0.56 
 
2.78 ± 1.01 1.256 ± 0.001 1.253 ± 0.018 
Statistical differences 
using ANOVA 
p<0.01 P=0.36 P<0.005 P<0.01 
 
Radiography 
Radiographs of the specimens (Figure 4) show 
the range of pores found through the 
specimens. For the SSR specimens, the gauge 
sections of Refobacin® Bone Cement R 
(Figure 4a) and Refobacin® Palacos R (Figure 
4b) show more small and defuse pores (less 
than 0.5 mm diameter) compared to the gauge 
sections of Refobacin® Plus Bone Cement 
(Figure 4c) and Palamed® G (Figure 4d). Also 
for the Refobacin® Bone Cement and 
Refobacin® Palacos R there are more pores on 
the edges of the specimens than the other two 
cements. Through all these specimens the 
gauge sections had fewer pores than the ends 
of the specimens. The radiographic density is 
reduced in the dumbbell ends, but these 
sections are only used for gripping, so are not 
relevant to the fatigue life. For the MSC 
specimens a few larger pores (around 0.5 to 
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0.8 mm diameter) were seen in all the 
specimens, but no differences in number or 
size of pores could be seen between any of the 
four cements.  
 
  
a) Refobacin® Bone Cement R   b) Refobacin® Palacos R, 
 
  
c) Refobacin® Plus Bone Cement  d) Palamed G 
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e) Refobacin® Bone Cement R  f) Refobacin® Palacos R 
    
g) Refobacin® Plus Bone Cement   h) Palamed G 
Figure 4 Radiographs of fractured rectangular a) Refobacin® Bone Cement R, b) Refobacin® 
Palacos R, c) Refobacin® Plus Bone Cement, d) Palamed® G, and circular e) Refobacin® Bone Cement 
R, f) Refobacin® Palacos R, g) Refobacin® Plus Bone Cement, h) Palamed® G cross sectional specimens 
used for the single stress level and multiple stress level tests respectively 
 
 
Scanning Electron Microscopy-
Fractography 
The Scanning Electron Micrographs are shown 
in Figures 5 to 6. At low magnification (not 
shown) pores of varying sizes are seen in the 
fracture surfaces of the SSR specimens 
whereas the more uniform fracture surfaces of 
the MSC specimens indicate the selective 
removal of specimens with pores greater than 
1mm in diameter from the groups. There are 
no substantial differences in the fracture 
surfaces in different cements for either fatigue 
method. A few pores about 500 µm can be 
found in all the cements. The topography of 
fracture surface from some low stress level 
(±10 MPa) showed some uneven surfaces, 
while the surface of high stress level (±30 
MPa) appeared fairly smooth.  
At higher magnification the fracture surfaces 
from the SSR specimens (Figure 5) look fairly 
flat in the form of a series of interconnecting 
flat zones, with a few pores up to 50µm across 
and some smaller pores visible. Some opacifier 
particles are visible in all the fracture surfaces. 
The fracture surface from the MSC specimens 
(Figure 6 a and c) was undulating in low stress 
level (±10 MPa) for Refobacin® Bone Cement 
R and Refobacin® Palacos R. The fracture line 
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appears to be passing over the original polymer 
beads with both positives and negatives of the 
beads visible on the surface. However, at the 
high stress level (±30 MPa) in both these 
cement (Figure 6 b and d) a series of flat 
sections are seen similar to the results seen in 
the rectangular specimens shown in Figure 5. 
However, the fracture surface from 
Refobacin® Plus Bone Cement and Palamed G 
were quite similar, both cements showed 
smooth surfaces at low and high stress levels 
(Figure 6 e to h). On all the surfaces of Figure 
5 and 6 zirconium dioxide opacifier particles 
and the negative impressions, where they were 
present on the opposing surface, can be seen 
although it does appear that there are more on 
the surfaces where the crack appears to have 
tracked around the edge of the pre-polymerised 
polymer beads than where the crack has 
progressed through the pre-polymerised 
polymer beads.  
 
 
  
a) Refobacin® Bone Cement R b) Refobacin® Palacos R 
   
c) Refobacin® Plus Bone Cement d) Palamed® G 
Figure 5 Higher magnification scanning electron micrographs of rectangular cross sectional 
specimens of a) Refobacin® Bone Cement R, b) Refobacin® Palacos R, c) Refobacin® Plus Bone 
Cement, d) Palamed® G. All scale bars = 100µm. 
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a) Refobacin® Bone Cement R tested at ±10MPa, b) Refobacin® Bone Cement R tested at ±30MPa 
   
c) Refobacin® Palacos R tested at ±10MPa, d) Refobacin® Palacos R tested at ±30MPa, 
  
e) Refobacin® Plus Bone Cement tested at ±10MPa, f) Refobacin® Plus Bone Cement tested at ±30MPa, 
  
g) Palamed G tested at ±10MPa and h) Palamed G tested at ±30MPa 
 
Figure 6 Higher magnification scanning electron micrographs of rectangular cross sectional 
specimens of a) Refobacin® Bone Cement R tested at ±10MPa, b) Refobacin® Bone Cement R tested at 
±30MPa, c) Refobacin® Palacos R tested at ±10MPa, d) Refobacin® Palacos R tested at ±30MPa, e) 
Refobacin® Plus Bone Cement tested at ±10MPa, f) Refobacin® Plus Bone Cement tested at ±30MPa, g) 
Palamed® G tested at ±10MPa and h) Palamed® G tested at ±30MPa. All scale bars = 100µm 
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DISCUSSION 
Both methods of testing show an increase in 
the fatigue life for Refobacin® Plus Bone 
Cement compared to Refobacin® Bone 
Cement and Refobacin Palacos® R. These 
are different formulation cements with 
Refobacin® Plus Bone Cement and 
Palamed® G having a higher powder-to-
liquid ratio and lower zirconium dioxide 
content than the other pair of cements 
(Table 1). The antibiotic content is similar 
in the four cements and although these levels 
of antibiotic are clinically effective [23,24] 
they are not thought to significantly affect 
the mechanical properties of the cement 
[22,25]. Only the SSR specimens indicate an 
increase in the fatigue life for Palamed® G 
compared to Refobacin® Bone Cement R 
and Refobacin Palacos® R and no significant 
difference between Refobacin® Plus Bone 
Cement and Palamed® G. The Wöhler 
analysis using the MSC specimens shows an 
increase over all the stress levels for 
Refobacin® Plus Bone Cement compared to 
the Refobacin® Bone Cement R and 
Refobacin Palacos® R, with no substantial 
differences seen between the Palamed® G 
and the other two cements. Furthermore the 
SSR tests show a factor of 11-15 difference 
in the mean fatigue lives between the 
cements whereas the MSC data showed an 
factor of 2 difference over all the stress 
levels combined and a maximum factor of 5 
difference at the lowest stress level. 
The decreased fatigue lives for the higher 
zirconium dioxide content and lower powder 
to liquid ratio cements may have various 
causes. Reduction in the fatigue life with 
increased opacifier content has been 
reported [25] as the particles act as stress 
concentrators in the cement therefore either 
initiating or propagating cracks. 
Furthermore, when the opacifier accumulates 
at the surface of the pre-polymerised beads 
and the specimen is loaded at low stress 
levels, instead of the crack front propagating 
through the specimen and passing through 
the original polymer beads and through the 
in situ polymerized monomer, as happens 
with the Refobacin® Plus Bone Cement and 
Palamed® G, the crack tip follows the 
interface between the original polymer beads 
and the in situ polymerized monomer. This 
behaviour is due to a combination of the 
agglomeration of the opacifier particles on 
the surface of the original polymer beads 
[26], thus generating a zone of weakness, 
and by the in situ polymerized monomer 
having a lower molecular weight and thus 
lower strength. Increased opacifier allows 
more agglomeration at the bead surfaces and 
with more in situ polymerized monomer, 
both the in situ polymerized monomer and 
the interface between the beads will be 
weaker. At lower stress levels the reduced 
crack velocity allows the crack front to be 
deflected through the weaker regions. 
Therefore two questions remain: why are the 
differences large with the SSR regime and less 
with the MSC regime and are the differences 
seen between these cements significant for 
the surgeon when choosing a cement for 
clinical applications. Harper and Bonfield [8] 
used the same SSR test regime, except that 
their aging and testing was performed in air 
at room temperature, and even excluding 
Boneloc® found a factor of 100 difference 
between the shortest and longest fatigue 
lives. Dunne et al. [10] using one cement and 
various mixing systems also in rectangular 
cross section specimens found a factor of 2.4 
difference between the shortest and longest 
median fatigue lives calculated using Weibull 
statistics. Lewis and Janna [18] using both 
rectangular and circular cross-section 
specimens of three cements and two mixing 
methods in fully reversed tension-
compression found a factor of 25 between 
the shortest and longest fatigue lives for 
rectangular specimens compared with a 
factor of 90 for the circular cross-section 
specimens, but always found that the circular 
specimens gave a longer fatigue life. They 
concluded that rectangular test specimens 
rather than circular cross-section should be 
used as these are more likely to exclude poor 
cements. However, all these authors 
performed their testing in air at room 
temperature without the plasticising effect 
of liquid immersion [9] which presumably 
occurred with both sets of specimens in this 
study. Also Lewis and Janna [18] did not age 
at physiological temperature and they found 
significant differences in the amount of 
residual non polymerised monomer in the 
cements, which should have been minimised 
in our studies by the identical ageing at 37˚C. 
Considering why our two test regimes found 
a factor of only 2 with one the MSC regime 
and over 10 with the SSR leads to 
consideration of the specimens and the test 
regimes. All the cements were mixed in a 
similar manner and were aged in PBS at 37˚C 
for 1 to 6 weeks so should be as polymerised 
as cement in clinical use. However, the 
radiographic and SEM analysis of the 
specimens shows that the SSR specimens of 
Refobacin® Bone Cement R and Refobacin 
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Palacos® R had more pores than SSR 
specimens of Refobacin® Plus Bone Cement 
and Palamed® G produced in the same 
manner or any of the MSC specimens 
therefore the lower fatigue lives for these 
specimens is only to be expected. There was 
a trend for lower density in these specimens 
although the differences were not 
statistically significant. In the case of the 
MSC specimens were excluded from the data 
analysis where there were pores greater than 
1mm across, while for the SSR specimens 
pores were allowed that are obvious in the 
radiographs, but were not visible when light 
was shone through the specimens prior to 
testing. It can be seen from the radiographs 
that for the MSC specimens the porosities 
were similar between all the cement whereas 
for the SSR specimens Refobacin® Bone 
Cement R and Refobacin Palacos® R were 
more porous and would therefore be 
expected to fail earlier. Therefore the MSC 
specimens are testing more similar materials 
than the SSR specimens due to the 
preparation methods and exclusion criteria 
used. Secondly, the SSR specimens had a 
factor of three greater surface area and 
rougher surfaces than the MSC specimens 
and the roughness difference was greater for 
Refobacin® Bone Cement R and Refobacin 
Palacos® R than Refobacin® Plus Bone 
Cement and Palamed® G. Therefore the 
cements with more inclusions, thus probably 
lower fracture toughness, although this 
toughness has not been measured, had more 
crack initiators on the larger surface area, 
thus again it is to be expected that with the 
rectangular cross-section specimens the 
differences in the fatigue lives would be 
greater than with the circular cross-sectional 
specimens. Finally, the SSR specimens 
undergo tension only so, although it was not 
measured in these studies, the dynamic creep 
would be expected to be greater than in the 
fully reversed tension-compression testing of 
the circular cross-section specimens [27]. 
Failure due to tensile creep in polymers is 
accelerated by the addition of non-bonded 
filler particles [28], thus in the cements with 
more non-bonded fillers, that is more 
radiopacifier, creep failure will be 
accelerated. Thus the substantially greater 
differences between the cements seen in the 
tension only tests compared to the fully 
reversed multi stress level tests are probably 
more to do with extrinsic than intrinsic 
factors. Secondly they are not loading the 
specimens over the range of stresses to 
which they are subjected in vivo. 
Which of these tests is more clinically 
relevant is a more difficult question to 
answer. Failure of bone cement has been 
reported as more common in areas of 
cement that are mainly in tension, thus 
indicating the tension only testing is 
clinically relevant. However cement in vivo 
is loaded in both tension and compression 
and at a range of stress levels thus the multi-
level testing can be considered to be more 
relevant. In vivo bone cement will contain 
pores of various sizes including those over 
1mm in diameter so the exclusion of 
specimens containing pores greater than 
1mm may be considered to be non-
physiological. Cristofolini et al. [22] showed 
that less than 10% of 1.1mm diameter pores 
initiated failure cracks whereas 50% of 
1.7mm diameter initiated the cracks that 
lead to specimen failure. In vivo cement will 
conform to the newly cut surfaces of the 
supporting cancellous bone and thus have 
substantially rougher surfaces than the 
machined specimens tested here in fully 
reversed tension-compression. The final 
consideration is the time to perform each 
test, the fully reversed tension-compression 
requires either 32 or 40 acceptable tests for 
each cement, depending on the number of 
stress levels considered, and that cements 
which fail through pores need to be replaced 
in the test regime. Whereas Weibull statistics 
requires a minimum of 10 specimens be 
tested, although more are advisable, and the 
rejection of the specimens takes place before 
testing, so all specimens entering the test 
regime will provide acceptable data points. 
Therefore the fully reversed tension-
compression testing requires approximately 
three times as many specimens. Although 
the tests at ±30MPa will take less than 1 
hour including initial stabilisation time those 
that run through to 5 million cycles take 
over 11 days per specimen, so the total 
testing time is substantially longer with the 
fully reversed tension-compression regime. 
In this study it appears that due to the 
exclusion criteria commonly used for tension 
only fatigue testing the specimens subjected 
to the fully reversed tension-compression 
testing were more similar specimens than 
those subjected to the tension only testing 
thus indicating that the difference of a factor 
of 2 in the fatigue life is probably nearer 
what will occur in vivo than the factors of 
over 10 seen with the tension only test 
specimens. 
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CONCLUSIONS 
The testing regime does alter the differences 
seen between these four bone cements, 
although the ranking remains the same. The 
S-N or Wöhler analysis with fully reversed 
tension-compression testing gives data 
throughout the stress spectra to which 
cement is exposed in vivo, while the single 
stress level tension only Weibull analysis 
investigates the repeatability of the cement. 
The tension only testing on rectangular 
specimens gives greater differences between 
the cements than fully reversed tension-
compression on circular cross-section 
specimens. These increased differences are 
due to both the differences in the porosity 
seen in the rectangular specimens, increased 
crack initiation points on the larger surfaces 
of the rectangular specimens due to increased 
surface roughness and finally increases in the 
opacifier content leads to earlier failure in 
tension only testing than in fully reversed 
testing. 
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